Third-generation EGFR-TKI, Irreversible inhibitor, Targets EGFR Ex19Del, EGFR L858R mutations, Cerebral metastasis activity,
Sale!
Lucius
Replica Osimertinib: Targeted EGFRm NSCLC Therapy
Original price was: $575.00.$416.00Current price is: $416.00.
Third-generation EGFR-TKI, Irreversible inhibitor, Targets EGFR Ex19Del, EGFR L858R mutations, Cerebral metastasis activity,
Reviews
There are no reviews yet.